where does henry meds get their semaglutide Wegovy Review: Program Overview and Approach Henry Meds Reviews | We

Average monthly weight loss on GLP-1 provides benchmarks to compare against

In August 2025 , the FDA approved Wegovy for another use: to treat a type of fatty liver disease called metabolic dysfunction-associated steatohepatitis (MASH) in adults who have moderate to advanced liver scarring (fibrosis) but do not have permanent liver damage (cirrhosis)

DISCUSSION In this study, 7.5 mg of tirzepatide did not produce significant improvements in glycemic control or body weight after switching from 1.0 mg of semaglutide, while the 10 mg dose resulted in significant HbA1c reduction, but not significant weight loss

If more than 3 days have passed, skip the missed dose and resume your normal weekly schedule

But how does Wegovy work, and why should you consider adding it to your regimen

We respond the same week